07/23/2024
3:47 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:21 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:11 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:24 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
5:15 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:06 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/08/2024
4:06 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:03 PM | Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
7:00 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:02 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:04 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:05 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:07 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:12 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:26 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
7:04 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:39 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:13 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:17 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:22 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:24 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:16 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:08 PM | Bhanji Muna (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
4:13 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
4:23 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
9:02 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:30 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:36 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:33 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:15 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:59 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:00 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:01 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:03 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:04 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:05 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:06 PM | COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:17 PM | Bhanji Muna (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:00 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The asset beating inflation by 4x (Ad) Central Bank Gold Heist In Progress
Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Retirement Protection Kit, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too. Click here to get your free copy today. |
05/08/2024
6:05 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:37 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:30 PM | Cytokinetics (Issuer)
Lee Sung (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/25/2024
5:54 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:38 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:35 PM | Cytokinetics (Filer)
| Form DEF 14A | |
04/08/2024
3:37 PM | Cytokinetics (Filer)
| Form ARS | |
04/05/2024
6:30 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:57 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
6:02 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
6:07 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:52 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:26 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
7:50 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
3:43 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:38 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:41 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
9:45 AM | Cytokinetics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
4:19 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
1:03 PM | BlackRock Inc. (Filed by)
Cytokinetics (Subject)
| Form SC 13G/A | |
01/19/2024
3:49 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
4:20 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
3:09 PM | Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:02 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
4:55 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:19 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:10 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
3:11 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
6:30 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
4:22 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
3:21 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/03/2023
4:30 PM | Cytokinetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2023
3:48 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
6:32 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
4:57 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
3:18 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/12/2023
5:39 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
3:22 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/06/2023
3:52 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:32 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:09 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023
3:13 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
8:06 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:09 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:18 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:09 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:09 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023
5:45 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:33 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
3:38 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Nvidia’s Quiet $1 Trillion Pivot (Ad) Nvidia recently added $277 billion in market cap …
IN ONE DAY. Find out details on these three critical Nvidia partners immediately. |
08/11/2023
4:32 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
4:18 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
3:14 PM | Cytokinetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
3:25 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
